About the Cell Therapy Portfolio
The Cell Therapy Global Series is dedicated to supporting industry and academia developing safe and effective adoptive cell therapy products to clinical promise, commercial-scale manufacturing and patients. Anchored around our flagship Onco-Cell Therapy Summit, this series of industry-led conferences provides engaging content and interactive discussions around the key development questions in autologous and allogeneic cell product advancements.
The Cell Therapy Global Series is your global, multi-channel resource to reach, engage and interact with the most influential and important stakeholders in cell therapy development. Attend one of our niche conferences to uncover advancements in cell engineering platforms for CAR T, TCR T, TILs, Macrophages, and NK cells products treating haematological and solid tumors, or how to build out commercial-ready manufacturing capabilities.